🔗 Share this article

Treasury head Reeves has revealed she is planning "targeted action to tackle household expense issues" in the forthcoming Budget.

Speaking to media outlets, she emphasized that reducing price rises is a collective duty of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the G7 advanced economies this year and the following year.

Possible Energy Cost Interventions

Sources suggest the government could intervene to bring down utility costs, for example by slashing the current 5% level of VAT applied on energy.

A further approach is to reduce some of the regulatory levies presently included in bills.

Budgetary Limitations and Analyst Expectations

The administration will obtain the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these measures.

The expectation from the majority of experts is that the Chancellor will have to declare tax increases or expenditure reductions in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, calculations suggested there was a £22bn gap for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the central bank and the administration to bear down further on some of the sources of inflation," Reeves told reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the most recent figures from the OBR had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing geopolitical and commercial tensions for the fiscal revenue measures, likely to be focused on those "with the broadest shoulders."

Global Economic Disputes

Addressing worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always come first."

Last week's announcement by Chinese authorities to tighten export controls on rare earths and other materials that are crucial for advanced tech manufacturing led US President the US President to suggest an further 100% import tax on imports from China, increasing the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese action "economic coercion" and "a international production power grab."

Questioned on considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "damaging for the international commerce and causes further headwinds."

"I believe there are fields where we need to confront China, but there are also valuable prospects to export to China's economy, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are less reliant."

NHS Drug Costs and Funding

The Chancellor also admitted that the cost the NHS pays for medicines could rise as a consequence of ongoing talks with the US government and its drugs companies, in exchange for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the UK, with several blaming the low prices they are getting.

Last month, the government science advisor said the cost the NHS pays for medicines would must rise to halt companies and drug research funding leaving the United Kingdom.

Reeves stated to the BBC: "It has been observed as a result of the payment system, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other EU nations."

"We want to make sure that patients receiving treatment from the National Health Service are can obtain the best life-saving drugs in the globe. And so we are examining these issues, and... looking to obtain more funding into Britain."